Metagenomi, Inc.
MGX
$2.02
-$0.05-2.42%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -74.81% | 57.30% | -30.34% | 2.65% | -52.37% |
| Total Depreciation and Amortization | 4.20% | 2.83% | 6.00% | 4.07% | 14.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.04% | -21.64% | 163.25% | -0.21% | 147.39% |
| Change in Net Operating Assets | 39.49% | -90.15% | -149.45% | 37.00% | 31.46% |
| Cash from Operations | -1.25% | 11.86% | -44.96% | 13.22% | 9.05% |
| Capital Expenditure | -80.45% | 27.32% | 47.32% | 23.11% | 28.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.48% | 86.81% | -250.42% | -20.19% | 601.95% |
| Cash from Investing | 31.47% | 86.24% | -256.24% | -20.10% | 505.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 75.79% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 30.16% | -4,797.44% |
| Cash from Financing | 75.79% | -102.35% | 6,587.03% | 30.16% | -4,797.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.84% | -8.76% | -198.29% | -22.97% | 212.04% |
